Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/99396e3f-111c-4aed-b169-975b7e94ba14/

INSP

Inspire Medical Systems Inc
Chart
50.60 USD
Latest Week 2026-07-17
Snapshot 2026-07-12 · 0.9w · Fresh
0.59
OS Score
69.0%
Value
74.0%
Quality
0.0%
Momentum
6/9
F-Score
0.715
QV
Strategy Eligibility
5 of 23 passing
OS Composite
Trending Value
Quality × Value
QV 0.715
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
ROE 17%
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
6.2%
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
Val 69%
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
CAQ 0.65
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
69.0%ile
P/E
11.4×
P/S
1.6×
P/B
1.9×
E/P
0.0451
FCF Yield
0.124
EBITDA/EV
0.056
SH Yield
0.062
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
31.00000000
/100 — 1=cheapest
VC2 (Trending Value)
26.00000000
/100
VC3 (Buyback)
29.00000000
/100
P/E of 11.4x places this firmly in deep value territory. FCF yield of 12.4% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
74.0%ile
ROE
0.166
ROA
0.144
Net Margin
0.143
Op Margin
0.070
GPA
0.861
D/E
0.15
Current
6.34
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.089
Earn Growth
0.972
Stability
1.909
lower=better
Accruals
-0.006
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.15.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
0.0%ile
6M Return
-47.4%
12M Return
-60.3%
12-1 Mom
-67.2%
Risk-Adj
-0.85
Vol 252d
79.5%
Vol 60d
172.6%
↑ Expanding
Max DD 12M
-70.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -67% signals a downtrend — price is moving against you. Near-term vol (173%) is expanding vs long-term (79%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.59
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
81.4%
Sector Quality %ile
80.0%
P/E z-score
-0.32
P/B z-score
-0.25
Sector Avg OS
63.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
TBPH Theravance Biopharma Inc 99.0% 90.0% 99.0% 88.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 90.0% 91.0% 99.0%
FBIO Fortress Biotech Inc 99.0% 98.0% 85.0% 90.0%
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 83.0% 95.0%
RIGL Rigel Pharmaceuticals Inc 99.0% 89.0% 93.0% 94.0%
INVA Innoviva Inc 98.0% 94.0% 94.0% 75.0%
NUTX Nutex Health Inc 98.0% 89.0% 98.0% 86.0%
CGEN Compugen 98.0% 89.0% 96.0% 85.0%
Factor Interactions
Falling Knife
Weak momentum (0th) despite looking cheap (69th value). Wait for momentum to stabilise.
Strong Capital Return
Shareholder yield 6.2% backed by 12.4% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (173%) significantly exceeds 252-day (79%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
70.9% avg (7 factors)
Quality
B
72.1% avg (8 factors)
Momentum
F
0.9% avg (4 factors)
Risk
F
0.0% avg (1 factors)
This stock sits in the O'Shaughnessy sweet spot — cheap AND high quality. Historically, this combination has generated the strongest long-term returns. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.590—0
Value %ile0.690—0
Quality %ile0.740—6
Momentum %ile0.000—6
F-Score6.000—0
Confidence0.951—6
Volatility0.795—6
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
11.37
Earnings Yield (E/P)
0.0451
Price / Sales
1.63
Price / Book
1.88
Price / Cash Flow
10.92
FCF Yield
12.4%
EBITDA / EV
5.6%
Sales Yield (1/P·S)
0.6436
Shareholder Yield
Div + net buyback / mktcap
6.2%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
16.6%
Return on Assets
14.4%
Net Margin
14.3%
Operating Margin
7.0%
Gross Profit / Assets
Novy-Marx GPA
86.1%
Debt / Equity
0.15
Current Ratio
6.34
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.006
External Financing
Net issuance — lower=better
0.119
MomentumPrice trend strength over different horizons
6M Return
-47.4%
12M Return
-60.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-67.2%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.85
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
8.9%
Earnings Growth (YoY)
97.2%
Earnings Stability (CV)
Lower = more stable
1.909
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Buyback Yield
6.2%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
31
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
26
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
29
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity